Home
Sun Pharmaceutical Industries Ltd Board of Directors
Board of Directors at Sun Pharmaceutical Industries Ltd
Whole Time Director
Company Sec. & Compli. Officer
Chairman & Managing Director
Non-Exec. & Independent Dir.
Lead Independent Director
Key Highlights
- Dilip S Shanghvi continues to serve as the Chairman & Managing Director in 2025, maintaining the same position as in the previous year.
- Gautam Doshi continues to serve as the Non Executive & Independent Director in 2025, maintaining the same position as in the previous year.
- Pawan Goenka continues to serve as the Lead Independent Director in 2025, maintaining the same position as in the previous year.
- Rama Bijapurkar continues to serve as the Independent Director in 2025, maintaining the same position as in the previous year.
- Anoop Deshpande continues to serve as the Company Sec. & Compli. Officer in 2025, maintaining the same position as in the previous year.

Sun Pharmaceutical Industries Ltd
NSE: SUNPHARMA
Share Price
Last Ten Days Market Price
Date | |
---|---|
17 Jul 2025 | 1703.25 |
16 Jul 2025 | 1700.85 |
15 Jul 2025 | 1727.7 |
14 Jul 2025 | 1682.05 |
11 Jul 2025 | 1672.5 |
10 Jul 2025 | 1663.15 |
09 Jul 2025 | 1667.15 |
08 Jul 2025 | 1672.85 |
07 Jul 2025 | 1679.8 |
04 Jul 2025 | 1676.65 |
Company Fundamentals for Sun Pharmaceutical Industries Ltd
Market Cap
408,666 Cr
EPS
47.8
P/E Ratio (TTM)
35.7
P/B Ratio (TTM)
5.7
Day’s High
1717.15
Day’s Low
1699.15
DTE
0.0
ROE
15.1
52 Week High
1960.2
52 Week Low
1555.0
ROCE
18.6
Market Price of Sun Pharmaceutical Industries Ltd
1M
1Y
3Y
5Y
Sun Pharmaceutical Industries Ltd News Hub
Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session
Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a
Read more
20 Aug 24
Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.
Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant
Read more
14 Aug 24
Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr
Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D
Read more
01 Aug 24
Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju
Read more
01 Aug 24
Document
Concalls
July 2024
PPTMay 2024
TranscriptMar 2024
PPTFeb 2024
TranscriptJan 2024
PPTNov 2023
TranscriptSep 2023
PPTMay 2023
TranscriptApr 2023
PPTNov 2022
TranscriptSep 2022
PPTAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptJan 2021
TranscriptJuly 2024
PPTMay 2024
TranscriptMar 2024
PPTFeb 2024
TranscriptJan 2024
PPTNov 2023
TranscriptSep 2023
PPTMay 2023
TranscriptApr 2023
PPTNov 2022
TranscriptSep 2022
PPTAug 2022
TranscriptJune 2022
TranscriptMar 2022
PPTFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptJan 2021
Transcript